Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985997 · ClinicalTrials.gov registry record
Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
A clinical trial of Observation Safety, sponsored by MedImmune.
- Completed
- Registry status
- 95,000
- Enrollment target
- 1
- Study location
NCT01985997: Completed study of Observation Safety, sponsored by MedImmune.
NCT01985997 is a study of Observation Safety that has completed, run by MedImmune. The registered enrollment target is 95,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01985997, a study of Observation Safety, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 95,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational post-marketing study conducted in children and adults immunized with Q/LAIV as part of routine clinical practice at Kaiser Permanente Northern California (NCKP) sites.
Primary Outcome
Rates of medically attended events from 0 to 3 days: hypersensitivity, seizures/convulsions
Conditions Studied
Study Locations (1)
California
- Research Site - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-07 |
What the finished NCT01985997 record still lists
NCT01985997 is an observational study that tracks outcomes without assigning an intervention. Its 95,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Observation Safety appearing as the primary indexed condition, and to 0 interventions.
NCT01985997 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01985997 about?
NCT01985997 is a clinical study titled "Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age". This is an observational post-marketing study conducted in children and adults immunized with Q/LAIV as part of routine clinical practice at Kaiser Permanente Northern California (NCKP) sites.
What is the current status of trial NCT01985997?
This trial is currently completed. The enrollment target is 95,000 participants. The study started on 2014-01. Estimated completion is 2014-07.
What conditions does trial NCT01985997 study?
This clinical trial studies the following conditions: Observation Safety.
Who is sponsoring clinical trial NCT01985997?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01985997 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01351545 · 99,999 participants
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia